Key result
Large LpA-I HDL particles contain ~19% fewer APOA1 molecules per particle than small particles.
Why the study?
Human HDL containing apolipoprotein A-I but not apolipoprotein A-II (LpA-I) is composed primarily of two discretely sized populations, requiring deep molecular characterization to understand the determinants of HDL particle size and protein cargo distribution.
Answers are grounded in this paper and cite their sources.
Demonstrates distinct size populations and APOA1 stoichiometry in human LpA-I particles, indicating that APOA2 drives broader HDL size heterogeneity.
Human high-density lipoproteins (HDLs) are a complex mixture of structurally related nanoparticles that perform distinct physiological functions. We previously showed that human HDL containing apolipoprotein A-I (APOA1) but not apolipoprotein A-II (APOA2), designated LpA-I, is composed primarily of two discretely sized populations. Here, we isolated these particles directly from human plasma by antibody affinity chromatography, separated them by high-resolution size-exclusion chromatography and performed a deep molecular characterization of each species. The large and small LpA-I populations were spherical with mean diameters of 109 Å and 91 Å, respectively. Unexpectedly, isotope dilution MS/MS with [ 15 N]-APOA1 in concert with quantitation of particle concentration by calibrated ion mobility analysis demonstrated that the large particles contained fewer APOA1 molecules than the small particles; the stoichiometries were 3.0 and 3.7 molecules of APOA1 per particle, respectively. MS/MS experiments showed that the protein cargo of large LpA-I particles was more diverse. Human HDL and isolated particles containing both APOA1 and APOA2 exhibit a much wider range and variation of particle sizes than LpA-I, indicating that APOA2 is likely the major contributor to HDL size heterogeneity. We propose a ratchet model based on the trefoil structure of APOA1 whereby the helical cage maintaining particle structure has two "settings"—large and small—that accounts for these findings. This understanding of the determinants of HDL particle size and protein cargo distribution serves as a basis for determining the roles of HDL subpopulations in metabolism and disease states.
No takes yet. Share an insight, caveat, or question.
Melchior et al. (2021) studied Normolipidemic healthy blood donors (n=3). Large LpA-I HDL subfraction (LpA-I L) vs. Small LpA-I HDL subfraction (LpA-I S) was evaluated on APOA1 stoichiometry (molecules of APOA1 per particle) and mean particle diameter. Large LpA-I HDL particles (109 Å diameter) contained fewer APOA1 molecules per particle than small LpA-I particles (91 Å diameter), with stoichiometries of 3.0 vs 3.7 molecules per particle.
Synapse has enriched 10 related papers. Consider them for comparative context: